Effects of Heat-Killed Lactiplantibacillus plantarum L-137 on Menopause-Related Outcomes and Gut Barrier-Related Biomarkers in Japanese Women: A Randomized, Double-Blind, Placebo-Controlled Trial
- 1Research & Development Institute, House Wellness Foods Corporation, 3-20 Imoji, Itami City 664-0011, Hyogo, Japan
Abstract
Background/Objectives: Menopause-related issues—such as mood disturbance, hot flashes, and sleep disturbance—are thought to be influenced not only by hormonal changes but also by everyday stress and gut barrier-related host responses. Heat-killed Lactiplantibacillus plantarum L-137 (HK L-137) has shown immunomodulatory and gut barrier-related effects, but clinical evidence for its effects in menopausal women is limited. We investigated whether HK L-137 intake affects menopause-related outcomes and gut barrier-related biomarkers in women reporting daily stress. Methods: We conducted a 12-week randomized, double-blind, placebo-controlled, parallel-group trial in healthy Japanese women aged 45–69 years who self-reported daily stress (UMIN000055687). Participants were randomly assigned to receive one tablet containing 10 mg HK L-137 or placebo daily. Mood state, menopausal symptoms, and sleep quality—as menopause-related outcomes—and gut barrier-related biomarkers were assessed at baseline and week 12. Results: A total of 121 participants were included, and 119 completed the study. No significant between-group differences were observed in the questionnaire scores of mood state, menopausal symptoms, or sleep quality. Changes in serum soluble CD14 (sCD14) and lactate dehydrogenase (LDH) differed significantly between groups, favoring the HK L-137 group (p = 0.020 and p = 0.010, respectively). In the prespecified subgroup with higher baseline levels of negative mood, HK L-137 significantly improved hot flashes item and sleep maintenance score, and was associated with favorable changes in sCD14, LDH, and body mass index versus placebo. No intervention-related safety concerns were identified. Conclusions: HK L-137 favorably affected sCD14 and LDH in the overall analysis and improved selected menopause-related outcomes in women with higher baseline levels of negative mood. These findings suggest a possible role of gut barrier-related host responses associated with microbial translocation.
Related
- Adjunctive Psychobiotic Lactiplantibacillus plantarum PS128 Therapy and Escitalopram in Major Depressive Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial
- Lactiplantibacillus plantarum PD01 supplementation reduces microplastics and microplastic-associated chemicals in humans: A randomized, double-blind, placebo-controlled trial.
- Impact of Lactiplantibacillus plantarum UBLP-40 intervention on iron status indicators in iron-deficient women of reproductive age: a double-blind, randomized controlled trial
- Study of Menopause and Resistance Training for Brain Health (SMART brain): a randomized controlled trial
- Feline-Derived Lactiplantibacillus plantarum-Aloe Vera Polysaccharide Hydrogel as a Topical Control Strategy for Staphylococcus pseudintermedius-Infected Wounds.
BibTeX
@article{nakajima2026effects,
title = {{Effects of Heat-Killed Lactiplantibacillus plantarum L-137 on Menopause-Related Outcomes and Gut Barrier-Related Biomarkers in Japanese Women: A Randomized, Double-Blind, Placebo-Controlled Trial}},
author = {Tsubasa Nakajima and Tatsuya Ohara and Yoshitaka Hirose and Kengo Kawasaki},
journal = {Nutrients},
year = {2026},
month = oct,
doi = {10.3390/nu18213641},
url = {https://www.mdpi.com/2072-6643/18/21/3641},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Effects of Heat-Killed Lactiplantibacillus plantarum L-137 on Menopause-Related Outcomes and Gut Barrier-Related Biomarkers in Japanese Women: A Randomized, Double-Blind, Placebo-Controlled Trial
AU - Tsubasa Nakajima
AU - Tatsuya Ohara
AU - Yoshitaka Hirose
AU - Kengo Kawasaki
PY - 2026
DA - 2026/10/31
JO - Nutrients
DO - 10.3390/nu18213641
UR - https://www.mdpi.com/2072-6643/18/21/3641
AB - Background/Objectives: Menopause-related issues—such as mood disturbance, hot flashes, and sleep disturbance—are thought to be influenced not only by hormonal changes but also by everyday stress and gut barrier-related host responses. Heat-killed Lactiplantibacillus plantarum L-137 (HK L-137) has shown immunomodulatory and gut barrier-related effects, but clinical evidence for its effects in menopausal women is limited. We investigated whether HK L-137 intake affects menopause-related outcomes and gut barrier-related biomarkers in women reporting daily stress. Methods: We conducted a 12-week randomized, double-blind, placebo-controlled, parallel-group trial in healthy Japanese women aged 45–69 years who self-reported daily stress (UMIN000055687). Participants were randomly assigned to receive one tablet containing 10 mg HK L-137 or placebo daily. Mood state, menopausal symptoms, and sleep quality—as menopause-related outcomes—and gut barrier-related biomarkers were assessed at baseline and week 12. Results: A total of 121 participants were included, and 119 completed the study. No significant between-group differences were observed in the questionnaire scores of mood state, menopausal symptoms, or sleep quality. Changes in serum soluble CD14 (sCD14) and lactate dehydrogenase (LDH) differed significantly between groups, favoring the HK L-137 group (p = 0.020 and p = 0.010, respectively). In the prespecified subgroup with higher baseline levels of negative mood, HK L-137 significantly improved hot flashes item and sleep maintenance score, and was associated with favorable changes in sCD14, LDH, and body mass index versus placebo. No intervention-related safety concerns were identified. Conclusions: HK L-137 favorably affected sCD14 and LDH in the overall analysis and improved selected menopause-related outcomes in women with higher baseline levels of negative mood. These findings suggest a possible role of gut barrier-related host responses associated with microbial translocation.
SN - 2072-6643
ER -